Kwangdong Pharmaceutical Appoints Sangyoung Park as New CEO... Implements Dual CEO System with Chairman Sungwon Choi
Independent Decision-Making and Responsible Management in Each Area of Expertise
On December 4, Kwangdong Pharmaceutical announced that its board of directors has newly appointed Sangyoung Park, President and Chief Operating Officer, as CEO. The company will implement a dual CEO system, with Sungwon Choi, Chairman and CEO, and Sangyoung Park each serving as independent CEOs.
(From left) Sungwon Choi, Chairman and CEO of Kwangdong Pharmaceutical, Sangyoung Park, President and CEO. Kwangdong Pharmaceutical
View original imageThis organizational restructuring aims to enhance management efficiency and proactively respond to the rapidly changing industrial environment by allowing the two CEOs to make independent decisions and take responsibility in their respective areas of expertise.
Sungwon Choi, Chairman and CEO, will serve as the Chief Executive Officer overseeing strategy, new business, research, and development (R&D). He will focus on establishing the company’s mid- to long-term vision and securing future growth engines. He will lead the discovery and investment in new businesses, as well as the development of R&D strategies, with the goal of building a foundation for Kwangdong Pharmaceutical’s future growth.
Sangyoung Park, President and CEO, will oversee major business divisions and support organizations as the Chief Operating Officer, taking overall responsibility for organizational operations. He plans to strengthen the execution of company-wide management activities and enhance the competitiveness of the business.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- "Reporters Who First Revealed Jo Jinwoong's Juvenile Offense History Cleared of Juvenile Act Violation"
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
A Kwangdong Pharmaceutical official stated, “The introduction of the dual CEO system is a strategic decision for the company’s sustainable growth,” adding, “Based on the expertise and experience of both CEOs, we will strengthen the competitiveness of our core businesses and systematically implement our mid- to long-term growth strategies.”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
